Markets:

Overview

News

Currencies

International

Treasuries

Harpoon Therapeutics, Inc. - Common Stock (NQ:HARP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 8, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harpoon Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Analyst Scoreboard: 4 Ratings For Harpoon Therapeutics ↗

February 26, 2024

Via Benzinga

Harpoon Therapeutics Inc. (NASDAQ: HARP) Records 52-Week High Thursday Morning

February 22, 2024

Via Investor Brand Network

Merck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growth ↗

February 01, 2024

Merck reports fourth quarter 2023 sales of $14.63 billion, a 6% YoY increase, beating estimates. Explore oncology, vaccines, and EPS outlook for 2024.

Via Benzinga

Investor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earnings ↗

January 29, 2024

Merck stock has gained 20% since Nov. 28; a technical signal suggests the rally isn't over. Keytruda approvals also drive optimism.

Via Benzinga

This 1 Bullish Move by Merck Could Drive Growth for Years to Come ↗

January 23, 2024

It's buying a company with sophisticated biotechnology platforms that could drive lots of growth -- eventually.

Via The Motley Fool

The 3 Best Dividend Growth Stocks to Buy in January 2024 ↗

January 17, 2024

These are the best dividend growth stocks to buy as they represent companies with healthy free cash flow upside visibility.

Via InvestorPlace

Peeling Back The Layers: Exploring Harpoon Therapeutics Through Analyst Insights ↗

January 16, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

January 16, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗

January 12, 2024

The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.

Via Investor's Business Daily

Topics ETFs

HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARP

January 10, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

January 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results ↗

January 08, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 37,596.43 while the NASDAQ rose 1.89% to 14,799.21. The...

Via Benzinga

Topics Stocks

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

Harpoon Therapeutics Inc. (NASDAQ: HARP) Near the Top of Equities by Percentage Gain on 1/8

January 08, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 08, 2024

Via Benzinga

Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher ↗

January 08, 2024

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded down 0.19% to 37,396.28 while the NASDAQ rose 1.20% to 14,698.88. The S&P 500...

Via Benzinga

Topics Stocks

Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal ↗

January 08, 2024

Monday, Johnson & Johnson (NYSE: JNJ) has agreed to acquire Ambrx Biopharma Inc (NASDAQ: AMAM) in an all-cash merger transaction for a total equity value of approximately $2.0 billion, or $1.9 billi

Via Benzinga

Health Care Company Merck & Co Announces Acquisition of Harpoon Therapeutics ↗

January 08, 2024

Via Benzinga

US Stocks Mixed; Nasdaq Jumps Over 100 Points ↗

January 08, 2024

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.45% to 37,296.85 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Merck, the Dow's hottest stock, gets set to report Q4 financials

January 08, 2024

Up 5.7% year-to-date, pharmaceuticals - including MRK - are the best performing industry in the entire U.S. equity market, outpacing even biotech stocks.

Via MarketBeat

Topics Stocks

J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value ↗

January 08, 2024

The year's biggest medical conference kicked off with a melee of buyout news.

Via Investor's Business Daily

Why Is Spirit AeroSystems (SPR) Stock Down 14% Today? ↗

January 08, 2024

Spirit AeroSystems stock is falling hard on Monday as investors in SPR react to one of the company's flights experiencing a mid-air blowout.

Via InvestorPlace

Why Is LumiraDx (LMDX) Stock Down 13% Today? ↗

January 08, 2024

LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!

Via InvestorPlace

Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today? ↗

January 08, 2024

Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.

Via InvestorPlace

HARP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Harpoon Therapeutics, Inc. Is Fair to Shareholders

January 08, 2024

From Halper Sadeh LLC

Via Business Wire

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket ↗

January 08, 2024

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th....

Via Benzinga

Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today? ↗

January 08, 2024

Harpoon Therapeutics stock is rocketing higher on Monday as HARP investors react to Merck acquiring the company for $23 per share.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 08, 2024

Via Benzinga

Top 3 Health Care Stocks That May Plunge In January ↗

January 08, 2024

As of Jan. 8, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 08, 2024

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

Via InvestorPlace

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.